Moderna’s COVID-19 drug trial results expected in November, company says

Moderna started its 30,000-person research study in July. In August, the company signed a $1.5 billion contract with the U.S. federal government to supply 100 million doses of its vaccine..

In September, Moderna ended up being the very first company to release its trial procedure detailing how security and efficacy will be figured out after researchers asked vaccine makers to do so that outside experts could evaluate the procedure. Shortly after, Pfizer and AstraZeneca likewise launched their trial procedures..

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this material? View our policies by click on this link.

The timeline resembles Pfizers, which said recently that it must see information from its clinical trial suggesting whether the vaccine works by the end of October and might look for FDA approval by the end of November..

Mr. Bancel said its tough to predict exactly which week it will receive the trial results due to the fact that it depends upon the cases and number of people getting ill, the Journal reported..

Moderna CEO Stéphane Bancel stated Oct. 19 that the company anticipates interim results from its COVID-19 vaccine clinical trial in November, and the FDA could give emergency situation usage authorization in December if those results are favorable, The Wall Street Journal reported..

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this material? View our policies by clicking here.

Maia Anderson –
Tuesday, October 20th, 2020
Print|Email.

Mr. Bancel said at the end of September that Moderna will not seek FDA approval to use the vaccine in the general population till at least late January and that it wouldnt seek emergency usage authorization for front-line employees till a minimum of Nov. 25..

More posts on pharmacy: CVS to hire 15,000 staff members for influenza season7 things to understand about Pfizers COVID-19 vaccine timelineCOVID-19 vaccine acceptance reaches historic level of suspect, poll finds.